| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.0092 | 1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.0039 | 1 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |